Vacuum Blood Collection Devices Market is anticipated to reach US$ 4.79 billion by 2033


In 2023, the United States is expected to materialize as one of the most lucrative markets, accounting for a market share of over 87.3 % across North America.

The Vacuum Blood Collection Devices Market is forecast to expand at 6.3% CAGR over the estimated period, as per FMI's analysis. The industry's size is predicted to reach a market value of US$ 2.6 billion in 2023, and US$ 4.79 billion by 2033.

A pool of patients has led to a peak in laboratory diagnostic tests. These tests necessitate Vacuum Blood Collection Devices to proceed with medical treatment. Since blood bank centers and hospital facilities require modern equipment to expedite positive patient outcomes, the deployment of Vacuum Blood Collection Devices is projected to surge.

For Details on Vendors and Their Offerings – Request A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5363

Widely spreading healthcare system across the globe is fueling the uptake of advanced medical equipment like Vacuum Blood Collection Devices. Healthcare professionals are realizing the convenience and safety associated with these devices. As a result, they are pursuing the use of Vacuum Blood Collection Devices.

The market is further armed with government support in the form of different initiatives extended to increase the adoption of advanced medical technologies. In tandem with this, soaring rates of blood-borne diseases or hematological disorders like anemia, blood cancer, etc., are boosting the demand for blood collection devices. Whereas, transplantation procedures, surgeries, and transmissible transfusion infections, etc., are building up the market value.

Manufacturers are flocking to emerging economies to gain a foot in the lucrative market. Appealing factors like favorable policies for MNCs and an enormous population with poor lifestyle habits are favoring the incoming companies.

Businesses, however, should be wary of top challenges to sustain their position in the market. The first is the rising complexities of storing and shipping these devices. Another factor that might pose a market disrupter is the difficulty in maintaining the sterility of these devices. The vendors might also incur high costs while procuring and maintaining the temperature-regulated storage. Strict regulatory mandates have also made it difficult for manufacturers to enter the market.

Last few days to get reports at discounted prices, offer expires soon!

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-5363

Top Highlights from the FMI’s Analysis of the Vacuum Blood Collection Devices Market:  

  • The United States Vacuum Blood Collection Devices industry is projected to capture a market share exceeding 87.3% of North America in 2023.
  • Germany is projected to clutch an 18.9% market share of the Europe Vacuum Blood Collection Devices industry. 
  • The China Vacuum Blood Collection Devices industry is expected to trail at a CAGR of 9.7% over the next ten years.
  • The India Vacuum Blood Collection Devices industry is anticipated to register a CAGR of 8.2% in the following years.
  • Over the assessment period, the serum separation tubes segment is expected to stretch at a CAGR of 6.7%. 
  • The plastic/PET material segment is projected to secure 84.5% of the market in 2023.
  • The routine chemistry segment is estimated to multiply at a CAGR of 7.1% over the estimated period.
  • Diagnostics laboratories emerged as the chief leading end user, grasping 46.6% of the overall market.

Exclusive from FMI: News Reporting Competitive Scenario of the Market in Focus  

  • Greiner Bio-One launched MiniCollect PIXIE Heel Incision Safety Lancet in 2021. The device has been a crucial addition to the company's product portfolio. The new safety lancet is engineered for heel incision and comes in three varieties to serve patient-centric goals.
  • CSL Plasma and Terumo Blood and Cell Technologies together announced their collaboration in 2021. As a result of this collaboration, the companies aim to provide a novel plasma collection platform.
  • Quest Diagnostics Incorporated obtained Nationwide Laboratory Services, based in Boca Raton, in 2021. This new development is expected to widen the prospects of gaining insights and grabbing diagnostic innovation. An increase in healthcare accessibility is projected to empower South Florida’s communities with improved medical health. 

Major Players:

  • Becton
  • Dickinson & Company
  • Greiner Bio-One GmbH
  • Guangzhou Improve Medical Instruments Co., Ltd
  • AB Medical, Inc.
  • SARSTEDT AG & Co. KG
  • Cardinal Health
  • Others

Expand Operations in the Future - To Get Requisite Details, Ask for a Custom Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-5363

Vacuum Blood Collection Devices by Category

By Product:

  • Serum Separation Tubes
  • Serum Clot Activators/Serum Gel + Clot Activator
    • Silica
    • Thrombin
  • Plasma Analysis/Anti-coagulants
    • EDTA Tubes
    • Lithium Heparin
    • Sodium Heparin
  • Coagulation Analysis Tubes
  • Glucose Analysis Tubes
    • Sodium Fluoride
    • Potassium Fluoride
    • Fluoride Oxide
  • Others

By Material:

  • PET/Plastic
  • Glass

By Application:

  • Serology & Immunology
  • Routine Chemistry
  • Blood Typing
  • Molecular Genetics
  • Blood Sugar Assay
  • Others

By End User:

  • Diagnostic Centers
  • Hospitals & Clinics
  • Research & Academic Institutes
  • Veterinary Hospitals & Clinics

About Future Market Insights

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.

Contact Information

Future Market Insights

Future Market Insights, Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware

19713
United States
Phone :
View website

Published in

Health

Published on

Jul 04, 2023

Social Links